SMART-IBD App Trial
- Conditions
- Crohn DiseaseUlcerative ColitisInflammatory Bowel DiseasesIBD
- Registration Number
- NCT06023667
- Lead Sponsor
- Children's Hospital Medical Center, Cincinnati
- Brief Summary
The objective of this trial is to test whether a smartphone app, SMART-IBD, is effective in improving medication adherence and self-management skills in adolescents with IBD. The investigators will conduct a randomized control trial to compare a sample of 15 youth (ages 13-17) with IBD using an app that has educational content and medication reminders to 15 youth in an attention control group. The length of the intervention will include one month of baseline adherence data collection, one month of intervention, and one month of post-treatment adherence data collection.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 45
- Patient diagnosed with Crohn's disease, ulcerative colitis, or indeterminate colitis (collectively IBD)
- Prescribed at least one medication used to treat IBD, regardless of route of administration
- Access to internet or wi-fi or data plan and access to smartphone
- English fluency for patient and clinician
- Diagnosis of pervasive developmental disorder in patient or caregiver as determined by medical chart review
- Diagnosis of serious mental illness (e.g., schizophrenia) in patient or caregiver as determined by medical chart review
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Primary Outcome Measures
Name Time Method Medication adherence 3 months Medication adherence will be measured using electronic monitoring of medications indicated being taken in the SMART-IBD app
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Cincinnati Children's Hospital Medical Center
🇺🇸Cincinnati, Ohio, United States
Cincinnati Children's Hospital Medical Center🇺🇸Cincinnati, Ohio, United States